Results 81 to 90 of about 24,578 (240)

Metformin as a Therapeutic Target in Endometrial Cancers. [PDF]

open access: yes, 2018
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its increasing incidence is thought to be related in part to the rise of metabolic syndrome, which has been shown to be a risk factor for the development of ...
Johnson, Jennifer   +6 more
core   +2 more sources

High-grade endometrial stromal sarcoma: a retrospective study of factors influencing prognosis

open access: yesCancer Management and Research, 2019
Objectives The aim of this study was to evaluate the factors associated with progress-free survival (PFS) and overall survival (OS) in patients with high-grade endometrial stromal sarcoma (HG-ESS).
Yan-Yan Zhang   +5 more
semanticscholar   +1 more source

Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy

open access: yesiMetaOmics, Volume 2, Issue 2, June 2025.
This study investigates the risk of thrombotic microangiopathy (TMA) induced by vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) inhibitors in cancer therapy. Using data from the FDA Adverse Event Reporting System (FAERS), the WHO Global Database for Adverse Drug Reactions (Vigibase), and The Cancer ...
Aimin Jiang   +7 more
wiley   +1 more source

Clinical characteristics of uterine sarcoma: Retrospective analysis of a single center

open access: yesMedicine Science, 2021
To examine the histopathological features and treatment modalities in patients with uterine sarcoma according to subgroups (uterine leiomyosarcoma, low grade/high grade endometrial stromal sarcoma, adenosarcoma, undifferentiated uterine sarcoma) and to ...
Songul Alemdaroglu   +5 more
doaj   +1 more source

Differences in the Sonographic Features of Adenomyosis and Concurrent Endometriosis Compared to Isolated Adenomyosis

open access: yesJournal of Ultrasound in Medicine, Volume 44, Issue 6, Page 1077-1084, June 2025.
Objective To examine whether the co‐occurrence of endometriosis affects the sonographic features of adenomyosis based on the revised Morphological Uterus Sonographic Assessment (MUSA) criteria. Methods This prospective cohort study utilized data from a tertiary referral center collected between 2010 and 2022.
Ran Matot   +8 more
wiley   +1 more source

Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma

open access: yesCancer Imaging, 2019
BackgroundEndometrial stromal sarcoma (ESS) is a rare uterine malignancy that features different prognoses for its high- and low-grade subtypes. We investigated the diagnostic accuracy of magnetic resonance (MR) imaging in diagnosing and differentiating ...
Yen-Ling Huang   +8 more
semanticscholar   +1 more source

A case of Low-grade endometrial stromal sarcoma with multiple metastasis [PDF]

open access: yes, 2006
Uterine sarcomas are rare tumors of mesodermal origin and constitute 2-6% of uterine malignancies. They are classified into leiomyosarcoma (LMS), malignant mixed mullerian tumors (MMMTs), and endometrial stromal sarcoma (ESS) by histologic types ...
김성훈   +5 more
core  

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist [PDF]

open access: yes, 2010
Endometrial stromal sarcoma (ESS) formerly classified as low-grade endometrial stromal sarcoma is a rare uterine malignancy with a good prognosis despite a tendency to recur.
DiSaia, Philip John   +1 more
core   +4 more sources

Endometrial Stromal Sarcomas [PDF]

open access: yesAmerican Journal of Clinical Pathology, 2014
We describe the morphologic and immunohistochemical features of 17 endometrial stromal neoplasms, 16 sarcomas, and one stromal nodule.We reviewed 35 cases interpreted as endometrial stromal neoplasms, but 17 high-grade endometrial stromal sarcomas (ESS) and one case of mixed endometrial sarcoma and leiomyosarcoma were excluded from the study. Data from
Jorge Albores-Saavedra   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy